This systematic review and meta-analysis aimed to determine the prognostic value of S-
100β protein to identify patients with post-concussion symptoms after a mild traumatic brain …

Objective: To determine the usefulness of S-100 β, a marker for central nervous system
damage, in the prediction of long-term outcomes after mild traumatic brain injury (MTBI) …

Objectives To determine the ability and accuracy of the S-100β protein in predicting
prognosis after a moderate or severe traumatic brain injury. Design Systematic review and …

Protein S-100B is an established serum marker of primary and secondary brain damage and
stroke. A group of patients after mild head injury (MHI) develop post-concussion symptoms …

INTRODUCTION: Prediction of the likely outcome of head injury from the outset would allow
early rehabilitation to be targeted at those with most to gain. Clinical evaluation of a head …

The objective of the study was to examine how S100B, a biomarker of traumatic brain injury
(TBI), contributes to outcome prediction after adjusting for known parameters, including age …

Background: Biochemical markers released after head injury may reflect the degree of brain
damage, which is related to subsequent disability. If the serum level of a marker were found …

Objective: To analyze the time course of serum protein S-100b in patients with traumatic
brain injury deteriorating to brain death and to investigate the predictive value of initial S …

Introduction Among children who sustain mild traumatic brain injury (mTBI), 10–30%
develop a cluster of cognitive, physical, and emotional symptoms commonly referred to as …

Objectives Traumatic brain injury is a common cause of death and disability worldwide.
Early recognition of patients with brain cellular damage allows for early rehabilitation and …